Common variable immunodeficiency. Epidemiology and clinical manifestations in 69 patients;Inmunodeficiencia común variable. Epidemiología y manifestaciones clínicas en 69 pacientes

Medicina (Argentina)

Volumn 73, Issue 4, 2013, Pages 315-323

  Fernández Romero, Diego S ^a,b,c   Juri, María C ^a,b,c   Paolini, María V ^c   Malbrán, Alejandro ^a,b  

^a Unidad de Alergia   (Argentina)

^b HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^c HOSPITAL DURAND   (Argentina)

Author keywords

Common variable immunodeficiency; Hypogammaglobulinemia

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BREAST CANCER; CHRONIC DIARRHEA; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GRANULOMATOSIS; HEMATOLOGIC DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOGLOBULIN DEFICIENCY; INTERSTITIAL PNEUMONIA; LYMPHOCYTE PROLIFERATION; LYMPHOID INTERSTITIAL PNEUMONITIS; MAJOR CLINICAL STUDY; ONSET AGE; SEPSIS; SPLENOMEGALY; STOMACH ADENOCARCINOMA; TUBERCULOSIS;

COMMON VARIABLE IMMUNODEFICIENCY; HYPOGAMMAGLOBULINEMIA;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARGENTINA; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE PROGRESSION; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SEX FACTORS; STOMACH NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84886859900     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Janeway C, Apt L, Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 1953; 66: 200-202.
2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodefciencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodefciencies). Clin Immunol 1999; 93: 190-197.
3. Primary immunodeficiency diseases. Report of an IUIS Scientifc Committee. International Union of Immunological Societies. Clin Exp Immunol 1999; 118: 1-28.
4. Hermaszewski RA, Webster AD. Primary hypogammag-lobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993; 86: 31-42.
5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
6. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308-316.
7. Oksenhendler E, Gérard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008; 46: 1547-1554.
8. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112: 277-286.
9. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268.
10. van Zelm MC, Reisli I, van der Burg M, et al. An antibody defciency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354: 1901-1912.
11. Kanegane H, Agematsu K, Futatani T, et al. Novel mutations in a Japanese patient with CD19 defciency. Genes Immun 2007; 8: 663-670.
12. Kuijpers TW, Bende RJ, Baars PA, et al. CD20 defciency in humans results in impaired T cell independent antibody responses. J Clin Invest 2010; 120: 214-222.
13. van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010; 120: 1265-1274.
14. Warnatz K, Salzer U, Rizzi M, et al. B-cell activating factor receptor defciency is associated with an adult-onset antibody defciency syndrome in humans. Proc Natl Acad Sci U S 2009; 106: 13945-13950.
15. Salzer U, Chapel HM, Webster AD, et al. Mutations in TN-FRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37: 820-828.
16. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA defciency. Nat Genet 2005; 37: 829-834.
17. Pan-Hammarstr̈m Q, Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007; 39: 429-430.
18. Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007; 120: 1178-1185.
19. Salzer U, Bacchelli C, Buckridge S, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease causing from risk-increasing TN-FRSF13B variants in antibody deficiency syndromes. Blood 2009; 113: 1967-1976.
20. Conley ME, Dobbs AK, Farmer DM, et al. Primary B cell immunodefciencies: comparisons and contrasts. Annu Rev Immunol 2009; 27: 199-227.
21. Almejún MB, Sajaroff E, Galicchio M, et al. Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency. J Clin Immunol 2012; 32: 89-97.
22. Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94: S1-S63.
23. Nolte MT, Pirofsky B, Gerritz GA, et al. Intravenous immunoglobulin therapy for antibody defciency. Clin Exp Immunol 1979; 36: 237-243.
24. Roifman CM, Lederman HM, Lavi S, et al. Beneft of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med 1985; 79: 171-174.
25. Busse PJ, Razvi SF, Cunningham-Rundles C. Effcacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004.
26. de Gracia J, Vendrell M, Alvarez A, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004; 4: 745-753.
27. Chapel HM, Spickett GP, Ericson D, et al. The comparison of the effcacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000; 20: 94-100.
28. Guía de recursos en Enfermedades raras. IntraMed.net.era edición. 2009. http://www.intramed.net/userfles/fle/guia_web.pdf
29. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune defciency over 4 decades. Blood 2012; 119: 1650-7.
30. Fernández Romero DS, Juri MC, Paolini MV, Malbrán A. Inmunodefciencias humorales. Un estudio en tres centros de inmunología clínica de adultos en la ciudad de Buenos Aires. Medicina (B Aires) 2011; 71: 350-6.
31. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA defciency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-31.
32. Vorechovsky I, Webster AD, Plebani A, et al. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999; 64: 1096-109.
33. Pierson JC, Camisa C, Lawlor KB, Elston DM. Cutaneous and visceral granulomas in common variable immunodeficiency. Cutis 1993; 52: 221-2.
34. Torrelo A, Mediero IG, Zambrano A. Caseating cutaneous granulomas in a child with common variable immunodeficiency. Pediatr Dermatol 1995; 12: 170-3.
35. Malbrán A, Juri MC, Fernández Romero DS. Common variable immunodeficiency and granulomatosis treated with infiximab. Clin Immunol 2010; 134: 359-60.
36. Cunningham-Rundles, C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008; 28, S42-S5.
37. Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004; 83: 254-263.
38. Ardeniz Ö, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009; 133: 198-207.
39. Katzenstein A. Katzenstein's and Askin's surgical pathology of nonneoplastic lung disease. 3rd ed. Philadelphia: W.B. Saunders; 1997.
40. Mechanic LJ, Dikman S, Cunningham-Rundles C, Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997; 127: 613-617.
41. Bates CA, Ellison MC, Lynch DA, et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114: 415-421.
42. Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 2005; 5: 370-375.
43. Park JE, Beal I, Dilworth JP, et al. The HRCT appearances of granulomatous pulmonary disease in common variable immune defciency. Eur J Radiol 2005; 54: 359-364.
44. Torigian DA, LaRosa DF, Levinson AI, et al. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT fndings. J Thorac Imaging 2008; 23: 162-169.
45. Hampson FA, Chandra A, Screaton NJ, et al. Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders. Clinical Radiology 2012; 67: 587-595.
46. Liebow AA, Carrington CB. Diffuse pulmonary lymphore-ticular infiltrations associated with dysproteinemia. Med Clin North Am 1973; 57: 809-843.
47. Peralta G, Villagomez R, Bosio M, Quadrelli S, Chertcoff J, Vigovich F. Neumonía intersticial linfoidea asociada a inmunodefciencia común variable. Medicina (B Aires) 2011; 71: 462-464.
48. Fasano MB, Sullivan KE, Sarpong SB, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 1996; 75: 251-261.
49. Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol 2008; 128: 18-22.
50. Kanathur N, Byrd Jr. RP, Fields CL, Roy TM. Noncaseating granulomatous disease in common variable immunodeficiency. South Med J 2000; 93: 631-633.
51. Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 2: 263-266
52. Mellemkjær L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA defciency or common variable immunodeficiency and their relatives: A combined Danish and Swedish study. Clin Exp Immunol 2002; 130: 495-500.
53. Hermans PE, Huizenga KA: Association of gastric carcinoma with idiopathic late-onset immunoglobulin defciency. Ann Intern Med 1972; 76: 605-9.
54. Gompels MM, Hodges E, Lock RJ, Angus B, White H, Larkin A, et al. Lymphoproliferative disease in antibody defciency: A multicentre study. Clin Exp Immunol 2003; 134: 314-321.
55. Vajdic CM, Mao L, van Leeuwen MT, et al. Are antibody defciency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood 2010; 26: 1228-1234.
56. Conley ME, Ziegler MM, Borden S 4th, Huff DS, Boyle JT. Multifocal adenocarcinoma of the stomach in a child with common variable immunodeficiency. J Pediatr Gastroenterol Nutr 1988; 7: 456-460.
57. Dhalla F, da Silva SP, Lucas M, et al. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011; 165: 1-7.
58. Healy MJ. Hypogammaglobulinaemia in the United Kingdom. XII. Statistical analyses: prevalence, mortality and effects of treatment. Spec Rep Ser Med Res Counc 1971; 310: 115-123.